TRAVERSA SERGIO (Chief Executive Officer) purchased 36.2% of their position (265.98K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $178.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 8/28/2025ACC: 0001213900-25-081837
DirectorOfficer· Chief Executive Officer
Since Dec 2018
+265.98K
Net shares
Net buyer
$178.1K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
265.98K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+80.55K
Price / share
$0.62
Trade value
$49.94K
% of position
11.0%
8/26/2025
734.02K→814.57K
Common Stock
Direct
Shares
+129.46K
Price / share
$0.67
Trade value
$86.73K
% of position
15.9%
8/27/2025
814.57K→944.02K
Common Stock
Direct
Shares
+55.98K
Price / share
$0.74
Trade value
$41.42K
% of position
5.9%
8/28/2025
944.02K→1M
Total
Net shares
+265.98K
Net value
$178.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/26/2025 | P · Purchase | +80.55K | $0.62 | $49.94K | 11.0% | 734.02K | 814.57K |
| Common Stock Direct | 8/27/2025 | P · Purchase | +129.46K | $0.67 | $86.73K | 15.9% | 814.57K | 944.02K |
| Common Stock Direct | 8/28/2025 | P · Purchase | +55.98K | $0.74 | $41.42K | 5.9% | 944.02K | 1M |
| Total | +265.98K | $178.09K | ||||||
Derivative Transactions0
No derivative transactions reported